Literature DB >> 29284108

Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet?

Emmanuel Jesulola1, Peter Micalos2, Ian J Baguley3.   

Abstract

A number of factors (biogenic amine deficiency, genetic, environmental, immunologic, endocrine factors and neurogenesis) have been identified as mechanisms which provide unitary explanations for the pathophysiology of depression. Rather than a unitary construct, the combination and linkage of these factors have been implicated in the pathogenesis of depression. That is, environmental stressors and heritable genetic factors acting through immunologic and endocrine responses initiate structural and functional changes in many brain regions, resulting in dysfunctional neurogenesis and neurotransmission which then manifest as a constellation of symptoms which present as depression.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depression; Endocrine factors; Environmental factor; Genetic factor; Immunologic factor; Monoamine hypothesis; Neurogenesis; Pathophysiology

Mesh:

Substances:

Year:  2017        PMID: 29284108     DOI: 10.1016/j.bbr.2017.12.025

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  45 in total

Review 1.  Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies.

Authors:  Jennifer L McGuire; Laura B Ngwenya; Robert E McCullumsmith
Journal:  Mol Psychiatry       Date:  2018-09-13       Impact factor: 15.992

Review 2.  Tetrahydrobiopterin and Its Multiple Roles in Neuropsychological Disorders.

Authors:  S Swathi Krishna; Samson K Wilson
Journal:  Neurochem Res       Date:  2022-02-10       Impact factor: 3.996

3.  Impact of chronic sub-lethal methylparaben exposure on cardiac hypoxia and alterations in neuroendocrine factors in zebrafish model.

Authors:  Sweta Thakkar; Barathi Seetharaman; Vasantharekha Ramasamy
Journal:  Mol Biol Rep       Date:  2021-10-29       Impact factor: 2.316

Review 4.  Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors.

Authors:  Hongguang Ma; Boshi Huang; Yan Zhang
Journal:  Drug Discov Today       Date:  2020-07-09       Impact factor: 7.851

Review 5.  Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy.

Authors:  Cliff H Summers; Jazmine D W Yaeger; Clarissa D Staton; David H Arendt; Tangi R Summers
Journal:  Brain Res       Date:  2018-12-24       Impact factor: 3.252

6.  mGluR5 Facilitates Long-Term Synaptic Depression in a Stress-Induced Depressive Mouse Model.

Authors:  Xiangzhi Jiang; Wei Lin; Yuanyuan Cheng; Dongming Wang
Journal:  Can J Psychiatry       Date:  2019-09-16       Impact factor: 4.356

7.  β-arrestin 2 is essential for fluoxetine-mediated promotion of hippocampal neurogenesis in a mouse model of depression.

Authors:  Chen-Xin Li; Ying Zheng; Hong Zhu; Cheng-Wu Li; Zhang He; Cong Wang; Jian-Hua Ding; Gang Hu; Ming Lu
Journal:  Acta Pharmacol Sin       Date:  2021-02-01       Impact factor: 6.150

Review 8.  Exploring the Role and Potential of Probiotics in the Field of Mental Health: Major Depressive Disorder.

Authors:  Dinyadarshini Johnson; Sivakumar Thurairajasingam; Vengadesh Letchumanan; Kok-Gan Chan; Learn-Han Lee
Journal:  Nutrients       Date:  2021-05-20       Impact factor: 5.717

9.  Aerobic, resistance, and mind-body exercise are equivalent to mitigate symptoms of depression in older adults: A systematic review and network meta-analysis of randomised controlled trials.

Authors:  Kyle J Miller; Pinyadapat Areerob; Declan Hennessy; Daniela C Gonçalves-Bradley; Christopher Mesagno; Fergal Grace
Journal:  F1000Res       Date:  2020-11-13

Review 10.  Investigating the potential mechanisms of depression induced-by COVID-19 infection in patients.

Authors:  Ali Mohammadkhanizadeh; Farnaz Nikbakht
Journal:  J Clin Neurosci       Date:  2021-07-20       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.